![Robert Azelby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Azelby
Président chez
TANGO THERAPEUTICS, INC.
Fortune : 1 M $ au 31/08/2026
Profil
Robert W.
Azelby is currently Chairman at Tango Therapeutics, Inc. since 2026.
He is an Independent Non-Executive Director at ADC Therapeutics SA since 2023.
He serves as Non-Executive Director at Autolus Therapeutics Plc and Independent Director at Cardinal Health, Inc., both since 2024.
Formerly, Mr. Azelby was Chief Executive Officer at Masimo Corp.
from 2024 to 2025.
He was President, Chief Executive Officer & Director at Climb Bio, Inc. from 2020 to 2023 and at Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2019.
He was Independent Director at Clovis Oncology, Inc. from 2018 to 2023 and Independent Director at Terns Pharmaceuticals, Inc. from 2025 to 2026.
He held the role of Chief Commercial Officer & Executive VP at Juno Therapeutics, Inc. from 2015 to 2018.
He was Vice President & General Manager-Oncology at Amgen, Inc. from 2012 to 2015 and VP-Commercial Effectiveness Unit & General Manager at Amgen Europe BV.
He was Director at Immunomedics, Inc. in 2020, at Cascadian Therapeutics LLC from 2017 to 2018, and at the Alliance for Regenerative Medicine.
He was Independent Director at Chinook Therapeutics, Inc. in 2023.
Education includes an undergraduate degree from the University of Virginia and an MBA from Harvard Business School conferred in 1997.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/11/2025 | 4 085 ( 0 % ) | 958 423 $ | 31/08/2026 | |
ADC THERAPEUTICS LTD 0,09 % | 03/06/2026 | 112 805 ( 0,09 % ) | 131 982 $ | 31/08/2026 |
TANGO THERAPEUTICS, INC. 0,01 % | 19/06/2026 | 5 740 ( 0,01 % ) | 131 102 $ | 31/08/2026 |
| 29/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Robert Azelby
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Directeur/Membre du Conseil | 14/06/2023 |
| AUTOLUS THERAPEUTICS PLC | Directeur/Membre du Conseil | 09/01/2024 |
| CARDINAL HEALTH, INC. | Directeur/Membre du Conseil | 01/03/2024 |
| TANGO THERAPEUTICS, INC. | Président | 06/08/2026 |
Anciens postes connus de Robert Azelby
| Sociétés | Poste | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/05/2026 |
| MASIMO CORPORATION | Directeur Général | 01/02/2025 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
| CLOVIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 10/07/2023 |
| CLIMB BIO, INC. | Directeur Général | 13/02/2023 |
Formation de Robert Azelby
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Masimo Corp.
 Masimo Corp. Medical SpecialtiesHealth Technology Designs and manufactures non-invasive patient monitoring devices | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
